Publications by Hornykiewicz, Oleh, em.Prof. Dr. :
2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2002 2001 1999
| 2017 Original Articles | |||
| o | Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ (2017) Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders Brain, 140: 2460-2474 | ||
| o | Hornykiewicz O (2017) L-DOPA J Parkinson Dis, 7 (s1): S3-S10 | ||
| 2016 Original Articles | |||
| o | Furukawa Y, Rajput A, Tong J, Tomizawa Y, Hornykiewicz O, Kish S (2016) A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia: Table Neurology, 87 (10): 1060-1061 | ||
| o | Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O (2016) Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications Eur J Neurosci, 45: 192-197 | ||
| 2015 Original Articles | |||
| o | Hornykiewicz O (2015) 50 years of levodopa Movement Disorders, 30: 1008 | ||
| o | Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ (2015) Low levels of astroglial markers in Parkinson's disease: relationship to alpha-synuclein accumulation Neurobiol Dis, 82: 243-253 | ||
| o | Pifl C, Reither H, Hornykiewicz O (2015) The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter Eur J Pharmacol, 755: 119-126 | Article (PDF) | | ||
| 2014 Original Articles | |||
| o | Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O (2014) Is Parkinson's Disease a Vesicular Dopamine Storage Disorder? Evidence from a Study in Isolated Synaptic Vesicles of Human and Nonhuman Primate Striatum J Neurosci, 24: 8210-8218 | ||
| 2013 Original Articles | |||
| o | Pifl C, Hornykiewicz O, Blesa J, Adanez R, Cavada C, Obeso JA (2013) Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of Parkinsonism J Neurochem, 125: 657-662 | ||
| 2012 Original Articles | |||
| o | Pifl C, Stephen J, Kish SJ, Hornykiewicz O (2012) Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non-motor symptoms Movement Disorders, 27: 1618-1624 | ||
| o | J. Blesa, C. Pifl, M.A. Sánchez-González, C. Juri, M.A. García-Cabezas, R. Adánez, E. Iglesias, M. Collantes, I. Peñuelas, J.J. Sánchez-Hernández, M.C. Rodríguez-Oroz, C. Avendaño, O. Hornykiewicz et (2012) The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: A PET, histological and biochemical study Neurobiol Dis, 48: 79-91 | ||
| 2011 Original Articles | |||
| o | Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C (2011) Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice Neuroscience, 180: 280-292 | ||
| o | Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ (2011) Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain Neurobiol Dis, 41: 458-468 | ||
| o | Ouattara B, Gregoire L, Morissette M, Gasparini F, Vranesic I, Bilbe G, Johns DR, Rajput A, Hornykiewicz O, Rajput AH, Gomez-Mancilla B, Di PaoloT (2011) Metabotropic glutamate receptor type 5 in levodopa-induced motor complications Neurobiol Aging, 32: 1286-1295 | ||
| 2010 Original Articles | |||
| o | Hornykiewicz O (2010) A brief history of levodopa J Neurol, 257: S249-S252 | ||
| o | Tong J, Wong H, Guttman M, Ang L, Forno L, Shimadzu M, Rajput A, Muenter M, Kish S, Hornykiewicz O, Furukawa Y (2010) Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson´s disease and progressive supranuclear palsy: a comparative investigation Brain, 133: 172-188 | Article (PDF) | | ||
| 2009 Original Articles | |||
| o | Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ (2009) Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson´s disease Brain, 132: 1366-1375 | Article (PDF) | | ||
| o | Samadi P, Rajput A, Calon F, Gregoire L, Hornykiewicz O, Rajput AH, Di Paolo T (2009) Metabotropic glutamate receptor II in the brains of Parkinsonian patients J Neuropath Exp Neurol, 68: 374-382 | Article (PDF) | | ||
| 2008 Original Articles | |||
| o | Rajput A.H., Sitte H.H., Rajput A., Fenton M.E., Pifl C., Hornykiewicz O. (2008) Globus pallidus dopamine and Parkinson motor subtypes. Neurology, 70: 1403-1410 | Article (PDF) | | ||
| o | Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y (2008) Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease Brain, 131: 120-131 | Article (PDF) | | ||
| 2007 Original Articles | |||
| o | Tong J, Hornykiewicz O, Furukawa Y, Kish SJ (2007) Marked dissociation between high noradrenaline vs. low noradrenaline transporter levels in human nucleus accumbens J Neurochem, 102: 1691-1702 | ||
| 2006 Original Articles | |||
| o | Pifl C, Hornykiewicz O (2006) Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP treated rhesus monkeys. Neurochem Internat, 49: 519-524 | ||
| o | Tong J, Hornykiewicz O, Kish SJ (2006) Identification of a noradrenaline-rich subdivision of the human nucleus accumbens J Neurochem, 96: 349-354 | ||
| o | Tong J, Hornykiewicz O, Kish SJ (2006) Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline Arch Neurol, 63: 1724-1728 | ||
| 2006 Reviews | |||
| o | Hornykiewicz O (2006) The discovery of dopamine deficiency in the parkinsonian brain Neural Transm Suppl, 70: 9-15 | ||
| 2005 Original Articles | |||
| o | Woldman I, Reither H, Kattinger A, Hornykiewicz O, Pifl C (2005) Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase Neuropharmacology, 48: 525-537 | ||
| 2004 Original Articles | |||
| o | Pifl C, Khorchide M, Kattinger A, Reither H, Hardy J, Hornykiewicz O (2004) alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter Neurosci Lett, 354: 34-37 | ||
| o | Rajput AH, Fenton ME , Di Paolo T, Sitte H, Pifl C Hornykiewicz O (2004) Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off Parkinsonism & Related Disorders, 10: 221-226 | ||
| o | Calon F, Dridi M, Hornykiewicz O, Bédard PJ, Rajput AH, Di Paolo T (2004) Increased adenosine A2A receptors in the brain of Parkinson’s disease patients with dyskinesias. Brain, 127: 1075-1084 | ||
| o | Zecca L, Stroppolo A, Gatti A, Tampellini D, Toscani M, Gallorini M, Giaveri G, Arosio P, Santambrogio P, Fariello RG, Karatekin E, Kleinman MH, Turro N, Hornykiewicz O, and Zucca FA (2004) The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc Natl Acad Sci USA, 101: 9843-9848 | ||
| 2004 Reviews | |||
| o | Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonucelli U, Damier P, de Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E (2004) Levodopa in the treatment of Parkinson’s disease: current controversies Movement Disorders, 19: 997-1005 | ||
| o | Yamamoto K, Hornykiewicz O (2004) Proposal for a noradrenaline hypothesis of schizophrenia. Progr Neuro-Psychopharmacol & Biol Psychiat, 28: 913-922 | ||
| 2002 Original Articles | |||
| o | Pifl C, Kattinger A, Reither H, Hornykiewicz O (2002) Cellular effects of dopamine - beyond oxidative mechanisms Parkinsonism & Related Disorders, 8: 433-437 | ||
| 2001 Original Articles | |||
| o | Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O (2001) Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter FASEB J, 15: 1607-1609 | ||
| 1999 Original Articles | |||
| o | Furukawa Y, Nygaard TG, Gutlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ (1999) Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia Neurology, 53: 1032-1041 | ||
